$5.12
-0.03 (-0.58%)
Pain Therapeutics, Inc. (PTIE)
CAPS Rating:
A biopharmaceutical company that develops novel drugs for pain management and oncology.
A biopharmaceutical company that develops novel drugs for pain management and oncology.
Recs
New joint venture with King pharma may bring an abuse-free oxycontin to market which would be a blockbuster for the legal pharma market.